NTRK2 and acute lymphoblastic leukemia: One study found that NTRK2 activation cooperates with PTEN loss in T-ALL [45, 47] so it is tantalizing to hypothesize that this mutation acts in a similar way in these cells providing them with yet another survival advantage.